The ASX has edged up (modestly) on Tuesday after US stocks and gold surged overnight on rising rate-cut bets.
The medicinal cannabis purveyor Bioxyne was the top performing ASX biotech in 2024-25, recording a 300% share gain.
Brazilian Critical Minerals’ Ema in-situ recovery field trial has successfully produced a magnet rare earth oxide-rich leach solution.
Household wealth has hit $17.3 trillion for the first time, capping off a stellar five-year period and led higher by one key asset class.
Aldoro Resources expands first phase drilling at Kameelburg after assays extend mineralisation and hint at more riches at depth.
